Monday, June 05, 2017 1:00:00 PM
WHAT ABOUT THOSE REVENUES ?
There Was Suppose To Be $50M This Quarter.
But There Was Only $13M ... What Happened ?
ALL PROJECTIONS ARE JUST LIES !!!
WHAT ABOUT THAT NET INCOME ?
Q1-17 = Net Loss Was $37.4 Million
Q4-16 = Net Loss Was $48.8 Million ---> Revised Q4
Q4-16 = Net Loss Was $38.8 Million ---> Misleading Q4
Q3-16 = Net Loss Was $19.7 Million
Q2-16 = Net Loss Was $13.6 Million
Q1-16 = Net Loss Was $15.3 Million
All The Collaborations In The World
Won't Stop The Losses From Climbing
THEY TURNED OUT TO BE NET LOSSES !!!
WHAT ABOUT A POSITIVE EPS ?
Q1-17 = ($0.13)
Q4-16 = ($0.17) ---> Revised Q4
Q4-16 = ($0.14) ---> Misleading Q4
Q3-16 = ($0.08)
Q2-16 = ($0.06)
Q1-16 = ($0.07)
BUT ALWAYS NEGATIVE INSTEAD !!!
HOW ABOUT THAT DILUTION ?
Q2-17 = 500M ?
Q1-17 = 290M
Q4-16 = 277M
Q3-16 = 249M
Q2-16 = 223M
Q1-16 = 207M
IT WASN'T EVEN SUPPOSE TO HAPPEN !!!
WHAT ABOUT THAT ATM AGREEMENT ?
"At The Market" Issuance Sales Agreement with
FBR Capital Markets And Co. Under which the
Company may issue and sell Shs of its Stock,
having an aggregate offering of up to $50M.
GUESS WHAT'S HAPPENING THERE !!!
HOW ABOUT THAT REVERSE-SPLIT ?
"To The Moon" - "Sleeping Giant" - "Saving Lives" ... They Cried !
Those "Big Boys" Are Human Too. And They Messed Up Big Time !
Now They Have To Figure Out A Way To Take Money Out Of
Your Back Right Pocket, And Put It In Their Front Left Pocket.
EVERYONE SAID IT WOULD NEVER HAPPEN !!!
F I F T E E N - C E N T S
JMO
Recent AMRSQ News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:39 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 02/10/2024 02:24:29 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 02/10/2024 02:14:56 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:42:49 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 12/14/2023 09:34:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/13/2023 10:23:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 09:43:26 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM